GROUP F 3 MALEN VELAYUTHAM GOH KAY WIN

GROUP F 3 MALEN VELAYUTHAM GOH KAY WIN BEE PING PREMA SHALINI HAMSARATHI GUNALAN TARSIGA UNIKKRISNAN CRYNL TEO JIA YING ADRIAN PATRICK XAVIER VITHIYA SUSANNA ANIS GOWRI 1301 1010 3044 1301 1010 3017 1301 1010 3070 1301 1010 3004 1301 1010 3040 1301 1010 3072 1301 1010 3023 1301 1010 3022 1301 1010 3071 1301 1010 3062 1301 1010 3003 1301 1010 30? ?

Life style drug and Me-too drug

1. OVERVIEW OF “LIFESYLE DRUGS” ØAccording to a recent article in Nature Medicine, 1 the market for lifestyle drugs is forecast to rise from its current $20 billion to over $29 billion by 2007. As a result of this booming market, companies have invested over $20 billion in research on such drugs since the 1990 s. ØObviously, lifestyle drugs have important financial implications, but what exactly is a “lifestyle drug”? ØLifestyle drugs are taken in an attempt to increase personal life quality by means of attaining a certain psychosocially defined medical or beauty ideal, rather than to manage a medically identifiable, welldefined disease. ØOften, patients suffering from somatoform disorders such as hypochondriac disorders, body dysmorphic disorders, somatization disorders or persistent somatoform pain disorders may spontaneously ask physicians to prescribe them lifestyle drugs.

2. Why the world spend more money on life-style drug? The benefits of lifestyle drugs can include improved appearance, help with weight loss, a boost in selfimage and self-esteem, and a fix to embarrassing sexual complications. could be helpful for you to improve your health, perhaps as a preventive measure (losing weight, quitting smoking)

The lifestyle drug market is a growing segment of the pharmaceutical industry due to shifting regional conditions that affect a population both culturally and economically. We can attribute the rise in demand for lifestyle drugs to different factors, depending on the market: an aging, yet affluent, population; increased access to healthcare in emerging markets; a greater emphasis on illness and aging prevention; and increased marketing and branding efforts.

3. Why do ‘life-style’ drugs receive more attention from pharmaceutical company than other drugs? • These so-called lifestyle drugs treat toe fungus, obesity, baldness, face wrinkles and impotence. The market for such drugs is worth billions of dollars a year, and is one of the fastestgrowing product lines in the industry. • Rather than focus on curing life threatening diseases that would support the needs of these broader stakeholders, global pharmaceutical companies are only focused on satisfying their shareholders. • Researching and producing more “lifestyle drugs” is far more profitable to their bottom-line.

4. GIVE EXAMPLES ON HOW THE MONEY HAS BEEN SPENT ON “LIFESTYLE”DRUGS COMPARED TO OTHES According to a recent article in Nature Medicine, the market for lifestyle drugs is forecast to rise from its current $20 billion to over $29 billion by 2007. As a result of this booming market, companies have invested over $20 billion in research on such drugs since the 1990 s. From this it can be seen that a sum of money is spent for life-style drugs.

It has been told that life-style drugs are used to treat non-life threatening and non-painful conditions. Examples on how money has been spent are as follow: -conditions like Ø Baldness Ø Impotence Ø Wrinkles Ø Erectile dysfunction

Acne Ø Weight loss Ø Effects of aging Ø Improve mental agility Ø

http: //www. ncbi. nlm. nih. gov/pmc/articles/PMC 161729/ http: //www. johnshopkinshealthalerts. com/alerts/prescription_d rugs/Johns. Hopkins. Prescription. Drugs. Health. Alert_3241 -1. html http: //www. qualityhealth. com/health-lifestyle-articles/common -lifestyle-drugs-pros-cons http: //www. seegerweiss. com/law-practices/drug-injury/Social. Responsibility/ http: //www. ncbi. nlm. nih. gov/pmc/articles/PMC 161729/